MRI Scans to Predict Response to Dienogest in Endometriosis
Studies whether MRI findings can help predict pain response to dienogest in women with endometriosis.
Key facts
- Who runs it
- Chungnam National University Sejong Hospital
- Where
- Sejong, South KoreaSee the site
- Trial code
- Registry title
- MRI-Based Prediction of Dienogest Response in Endometriosis
- Status
- Recruiting
- People taking part
- 48 people, planned
- Started
- 14 Oct 2025
- Expected to end
- Mar 2027
- Type of study
- Observational
- Record updated
- 3 March 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for women aged 19 to 45 with endometriosis who are about to start dienogest as part of routine care. It studies whether MRI findings can predict how well the treatment works.
- Age
- 19 to 45 years
- Sex
- Women only
- Disease stage
- Endometriosis diagnosed by a board-certified obstetrician-gynecologist.
- Earlier treatment
- No hormonal treatment in the previous 3 months. Never treated with dienogest.
Main reasons for not taking part
- Has had dienogest treatment before
- Has a reason (contraindication) not to take dienogest
- Cannot have an MRI scan, for example because of metallic implants
- Is pregnant now or plans pregnancy within the next 6 months
- Poor general health, as judged by the investigator
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Female participants who have received a full explanation of the study and have provided written informed consent
- Women aged 19 to 45 years who have been diagnosed with endometriosis by a board-certified obstetrician-gynecologist
- Patients who have not received any hormonal treatment within the previous 3 months
- Patients who have never been treated with dienogest
Who cannot take part
- Patients with a history of treatment with dienogest
- Patients who are unable to undergo magnetic resonance imaging (MRI) (e.g., presence of metallic implants)
- Patients with poor general medical condition, as judged by the investigator
- Patients with contraindications to dienogest
- Patients who are currently pregnant or planning pregnancy within the next 6 months
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 19 and 45 years old?
Where in South Korea
- Sejong Chungnam National University HospitalSejong, South KoreaContact: Sukhwan Hyun, MD, PhDTaking people
About the trial
What the trial wants to find out
The goal of this prospective observational study is to learn whether magnetic resonance imaging (MRI) findings can help predict treatment response to dienogest in women with endometriosis. Endometriosis is a common gynecologic condition that can cause chronic pelvic pain and negatively affect quality of life. Although dienogest is widely used as a standard medical treatment, individual responses to treatment vary.
Read full original descriptionShow less
The main questions this study aims to answer are:
* Whether baseline MRI characteristics of endometriotic lesions are associated with improvement in pelvic pain after dienogest treatment. * Whether MRI findings can help identify patients who are more likely to benefit from dienogest therapy.
Participants diagnosed with endometriosis who are prescribed dienogest as part of their routine clinical care will be enrolled. This study does not assign any investigational intervention. Participants will undergo standard clinical follow-up, including pelvic pain assessment using visual analog scale (VAS) scores, quality of life questionnaires, and routine MRI examinations. Clinical and imaging data will be collected prospectively and analyzed to explore imaging predictors of treatment response.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Predicting the Efficacy of Dienogest in Patients With Endometriosis Using MRI
- Plain-language title
- MRI Scans to Predict Response to Dienogest in EndometriosisGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT07446608, who can take part
- Record updated
- 3 March 2026